Orchid Pharma Share price Data
Orchid Pharma share price is down -3.95% on 30-Mar-2026, Mon. 112.69k shares traded. Orchid Pharma current market price is Rs 482.45 and Orchid Pharma present Market capitalization is 2435 Crores (approx).
The stock is down -10.4% in 7 days,
down -22.2% in 1 month and
down -31.0% in 2 months.
Orchid Pharma results Sep 2025 (Standalone_YoY) Orchid Pharma revenue decline to 194 crores down -13% in Sep 2025 quarter, compared with 223 crores in Sep 2024. Orchid Pharma Net profit is 2 crores down -92% in Sep 2025 quarter, compared with 26 crores in last year same quarter. Please click Image for Daily Data and Results of the stock.
Last 7 days trading Data:
Date, Day : Price | Volume | % Change
27-03-26, Fri: 502.3 | 196.18k | -5.52%
23-03-26, Mon: 509.75 | 58.72k | -4.28%
20-03-26, Fri: 532.55 | 68.89k | 3.21%
19-03-26, Thu: 516 | 48.1k | -4.16%
18-03-26, Wed: 538.4 | 57.12k | 1.79%
Data update: 8pm(IST).
Please click below image link for Latest Data.
*** Data is only for info. Not buy/sell advice.
#orchidpharma
Click Image for Data | Scroll down for Comments.
About Orchid Pharma…
Orchid Pharma Founded: 1992
Orchid Pharma Headquarters: India
Orchid Pharma Number of employees: 838 (2023)
Orchid Pharma Parent organization: Dhanuka Laboratories Limited
Orchid Pharma Subsidiaries: Orchid Research Laboratories Limited…
Orchid Pharma Limited (Orchid) is an Indian pharmaceutical company that develops and manufactures active pharmaceutical ingredients (APIs) and finished dosage forms. It also conducts research, manufacturing, and marketing, and is involved in the entire pharmaceutical value chain, from discovery to delivery.
Orchid was founded in 1992 by Kailasam Raghavendra Rao, an IIM Ahmedabad alumnus, and is based in Chennai. As of 2007, it was one of the top 500 Indian companies by market capitalization. Orchid’s products include:
Anti-infectives
Anti-inflammatory
Central nervous system (CNS)
Cardio vascular segment (CVS)
Nutraceuticals
Other oral and sterile products
Orchid’s formulations include:
Cefixime Capsules, Acarbose Tablets, Clozapime Tablets, Clopidogrel Tablets, Desloratadine Tablets, and Cefoperazone and Sulbactam for Injection.
Orchid’s subsidiaries include:
Orchidpharma, Inc.
Orchid Research Laboratories Limited
Orchid Europe Limited
Bexel Pharmaceuticals Inc.
Diakron Pharmaceuticals, Inc.
.
* About Orchid Pharma information is from various sources on the internet.
( March 2024 ).
Please verify the official website of Orchid Pharma for the latest updated information.
Please visit
https://investinstocks.co.in/find-any-stock-of-Indian-stock-market/
to know about any company.
.
What’s your view on this stock? Please comment.
*Data is only for info. Not Buy or Sell advice.
*** Don’t waste your hard earned money by trading in stock market.
Don’t trade.
100% of the traders will loose money in the market.
“Invest in stock market.”
Consult financial expert before investing.
.
Results Declared Stocks 2025 Dec
Please encourage real Data. Please Share.
{{mpg_news1_desc}}
.
Orchid Pharma share price is down -5.52% on 27-Mar-2026, Fri. 196.18k shares traded. Orchid Pharma current market price is Rs 502.3 and Orchid Pharma present Market cap is 2555 Crores (approx).
The stock is down -6.7% in 7 days,
down -19.0% in 1 month and
down -28.8% in 2 months.
Orchid Pharma results Sep 2025 (Standalone_YoY) Orchid Pharma revenue decline to 194 crores down -13% in Sep 2025 quarter, compared with 223 crores in Sep 2024. Orchid Pharma Net profit is 2 crores down -92% in Sep 2025 quarter, compared with 26 crores in last year same quarter. Please click Image for Daily Data and Results of the stock.
Please click below image for latest data.
.
Orchid Pharma share price is Down -4.16% on 19-Mar-2026, Thu. 48.1k shares traded. Orchid Pharma current market price is Rs 516 and Orchid Pharma present Market cap is 2627 Crores (approx). Orchid Pharma results Sep 2025 (Standalone_YoY) Orchid Pharma revenue decline to 194 crores down -13% in Sep 2025 quarter, compared with 223 crores in Sep 2024. Orchid Pharma Net profit is 2 crores down -92% in Sep 2025 quarter, compared with 26 crores in last year same quarter. Please click Image for Daily Data and Results of the stock.
Please click below image for latest data.
Please click below image for latest data.
Please click below image for latest data.
Please click below image for latest data.
Please click below image for latest data.
Please click below image for latest data.
.
Orchid Pharma share price is Up 4.75% on 17-Mar-2026, Tue. 105.4k shares traded. Orchid Pharma current market price is Rs 528.95 and Orchid Pharma present Market cap is 2677 Crores (approx). Orchid Pharma results Sep 2025 (Standalone_YoY) Orchid Pharma revenue decline to 194 crores down -13% in Sep 2025 quarter, compared with 223 crores in Sep 2024. Orchid Pharma Net profit is 2 crores down -92% in Sep 2025 quarter, compared with 26 crores in last year same quarter. Please click Image for Daily Data and Results of the stock.
Please click below image for latest data.
.
Orchid Pharma share price is Down -1.24% on 27-Feb-2026, Fri. 244.48k shares traded. Orchid Pharma current market price is Rs 619.75 and Orchid Pharma present Market cap is 3149 Crores (approx). The stock is down -7.5% in 7 days, down -12.2% in 1 month and down -18.7% in 2 months.
Please click below image for latest data.
.
Please Donate
.
I’m working 24X7 for India to encourage investment in India.
(updating more than 5000 companies stock value data, analyzed data and their results data daily).
Please help me by donating something. help me Here..
Jai Hind.
I’m requesting the same to all the companies, whose data is been served to Investors, daily, forever. Thank you.
Helping the deserved is reaching God level!
.
.
Latest analyzed data updates daily at 8pm(IST).
Add this page to your ‘Home screen’.
Computers: Select Star (Add Bookmark).
.
Mobiles: Select Options (3 dots at top)
Select Open in chrome.
Select Star (Add Bookmark).
.
.
.
.
Latest analyzed Data available
from 8pm – 9am IST
InvestinStocks.co.in
Stock market rare data of India from Nifty – NSE, Sensex – BSE.
* Data is Only for educational purpose, not for trading.
* Please verify Data with latest sources.
* Consult your financial advisor before trading or investing in any stock.
.
Post Orchid Pharma Data to social media.
*Please click share button, Copy and paste below text to Content of the post.
Share price content:
Orchid Pharma share price is down -3.95% on 30-Mar-2026, Mon. 112.69k shares traded. Orchid Pharma CMP is Rs 482.45 and Orchid Pharma present MCap is 2435 Crs (approx).
…pls visit InvestinStocks.co.in
*** Data is only for info. Not buy/sell advice.
#orchidpharma
********************************************************
*Please click share button, Copy and paste below text to Content of the post.
Results content:
Orchid Pharma results Sep 2025 (Standalone_YoY) Orchid Pharma revenue decline to 194 crores down -13% in Sep 2025 quarter, compared with 223 crores in Sep 2024. Orchid Pharma Net profit is…Pls click site link for Latest Data.
*** Data is only for info. Not buy/sell advice.
#orchidpharma
*Click share button below, Copy and paste above text to Content of the post.
From Mahendra Bolla
